The first CTRC Cancer Pain Symposium will be held on Thursday, December 1, 2016. This event will showcase the vast research related to cancer pain taking place across UT Health San Antonio with the goal of developing inter-disciplinary collaborations targeting mechanisms and therapies for cancer pain.
The symposium will be held in the Mabee Conference Room (G406) at the Cancer Therapy and Research Center (CTRC) beginning at 8:00 a.m., and is open to anyone who would like to attend. Lunch will be provided. For catering inquiries please RSVP to email@example.com.
The agenda is as follows:
Welcome & Introductions
Dr. Cara Gonzales
Assistant Professor, Department of Comprehensive Dentistry
“Unravelling Oral Cancer Pain”
Dr. Shivani Ruparel
Assistant Professor/Research, Endodontics
“Development of Novel Capsazepine Analogs to Treat Cancer and Cancer Pain”
Dr. Stan McHardy
Director, Center for Innovative Drug Discovery
“Cellular mechanisms contributing to the pathogenesis of chemotherapy induced peripheral neuropathy (CIPN)”
Dr. Benjamin Eaton
Associate Professor, Department of Cellular and Integrative Physiology
“Pharmacological augmentation of NAMPT protects against paclitaxel-induced peripheral neuropathy”
Greehey Graduate Fellow, Department of Pharmacology
"Reversal of paclitaxel-induced peripheral neuropathy with ACY-241 (histone deacetylace inhibitor)"
Dr. Josephine Taverna
Drug Development Fellow, Department of Hematology/Oncology
“The Identification of Genes Underlying Peripheral Pain Induced by Chemotherapy Treatment”
Neuroscience Graduate Student, Department of Pharmacology
"Pain and Function in Cancer: Assessing for Outcome"
Dr. Maureen Simmonds
Professor, Department of Physical Therapy
“Ablative Treatment of Cancer Pain”
Dr. Ameet Nagpal
Assistant Professor, Department of Anesthesiology
“Implementation of the Edmonton Symptom Assessment Scale to Improve
Integration of Palliative Care Services in Ambulatory Oncology Settings”
Dr. Laura Tenner
Assistant Professor, Department of Medicine
“Implanted Pain Therapies for Cancer Pain and Persistent Neuropathic Pain”